Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jul;9(7):1843-1847.
doi: 10.21037/jtd.2017.06.127.

Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

Martin W Dünser  1 , Jens Meier  2
Affiliations
Editorial

Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

Martin W Dünser et al. J Thorac Dis. 2017 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators. Khanna A, et al. N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21. N Engl J Med. 2017. PMID: 28528561 Clinical Trial.

References

    1. Torgersen C, Dünser MW, Schmittinger CA, et al. Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey. Eur J Anaesthesiol 2011;28:284-90. - PubMed
    1. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009;24:293-316. 10.1177/0885066609340519 - DOI - PubMed
    1. Schmittinger CA, Torgersen C, Luckner G, et al. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012;38:950-8. 10.1007/s00134-012-2531-2 - DOI - PubMed
    1. Belletti A, Musu M, Silvetti S, et al. Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials. PLoS One 2015;10:e0142605. 10.1371/journal.pone.0142605 - DOI - PMC - PubMed
    1. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82. 10.1097/00003246-199708000-00012 - DOI - PubMed

LinkOut - more resources